CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
22 hedge funds and large institutions have $16.1M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding
Funds holding: 22 → 22 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
22
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1M | |
| 2 | +$319K | |
| 3 | +$211K | |
| 4 |
LWP
Legacy Wealth Partners
Calabasas,
California
|
+$151K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$120K |
Top Sellers
| 1 | -$806K | |
| 2 | -$50.6K | |
| 3 | -$32K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$26K |
| 5 |
LPL Financial
San Diego,
California
|
-$23.5K |